Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anticancer drug   Carmustine  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Becenun Brazil
Bicnu Australia, Canada, Chile, Colombia, France, Great Britain, Greece, Hungary, Iran, Ireland, Mexico, Morocco, New Zealand, Peru, Romania, Spain, Switzerland, Tunisia, United States of America
Bodacler Argentina
Carmubris Austria, Germany, Iran
Carmustina Grey Peru
Carmustina Perulab Peru
Carmustine Baxter New Zealand
Carmustine Obvius Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Great Britain, Hungary, Iceland, Ireland, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Nitrourean Spain
Nitrumon Belgium, Iran, Luxembourg
Factors which affect stability   Injection   Factors which affect stability : Carmustine        
References
Storage Light Induces Degradation 837
Solvent NaHCO3 Induces Degradation 715
Container Polyvinyl chloride Induces Adsorption 837
Temperature Increase Induces Degradation 146
Temperature > 30°C Induces Degradation 3314
PH 3,3 < pH <4,8 Induces Enhanced stability 837
  Mentions Légales